Stock Earnings
Viridian Therapeutics Inc [VRDN] Investment Appeal on the Rise
In a filing, Viridian Therapeutics Inc revealed its Chief Operating Officer Beetham Thomas W. acquired Company’s shares for reported $0.12
Menu
In a filing, Viridian Therapeutics Inc revealed its Chief Operating Officer Beetham Thomas W. acquired Company’s shares for reported $0.12
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Viridian Therapeutics Inc revealed its Chief Operating Officer Beetham Thomas W. acquired Company’s shares for reported $0.12
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Viridian Therapeutics Inc’s recently made public that its Chief Operating Officer Beetham Thomas W. acquired Company’s shares for reported $0.12
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Viridian Therapeutics
Viridian Therapeutics Inc’s filing revealed that its Chief Operating Officer Beetham Thomas W. acquired Company’s shares for reported $0.12 million